Halder Venture Limited Receives ₹6.25 Crore Funding From P.K. Bio-Link
Key highlights
- Halder Venture Limited closed ₹6.25 crore of funding from P.K. Bio-Link Private Limited on July 24, 2026.
- Halder Venture agreed to acquire a 52% stake in InQube Technologies for about ₹30.16 crore.
- Halder Venture reported FY26 revenue of about ₹646 crore, while FY26 profit included a ₹30.97 crore foreign-exchange gain.
- Halder Venture's price-to-earnings ratio was 8.23 in the supplied peer-comparison data.
powered by IRIS

Halder Venture Limited closed ₹6.25 crore of funding from P.K. Bio-Link Private Limited on July 24, 2026, following shareholder approval. The transaction adds fresh disclosed funding as the integrated rice and edible oils company expands its Haldia infrastructure, distribution network and proposed agri-technology presence.
Know Halder Venture inside out
Results, valuation, peers and who's buying, in one view.
What funding did Halder Venture close?
Halder Venture closed funding of ₹6.25 crore from P.K. Bio-Link Private Limited on July 24, 2026. The company had first announced on March 29, 2026 that it expected to receive ₹6.25 crore from P.K. Bio-Link, after its board said on March 23 that it would consider fund raising.
The transaction was approved by shareholders before closing, according to the disclosed update. The available information does not specify the instrument used for the funding, the number of securities issued, the issue price or the intended use of the proceeds. Those details remain relevant for investors assessing any effect on share capital or the company’s funding position.
The development is part of a sequence of corporate actions during FY26. Halder Venture reported full-year results for the year ended March 31, 2026 on May 29, after announcing quarterly and nine-month results on February 13. The company also disclosed a strategic acquisition plan in February.
How does the InQube acquisition plan relate to Halder Venture's strategy?
Halder Venture has agreed to acquire a 52% stake in InQube Technologies Private Limited for about ₹30.16 crore. The board approved the investment and a term sheet on February 13, 2026, with the stated timeline for completion set at 24 months from the definitive agreements.
InQube operates a cloud-based, multilingual Agri-ERP platform and is involved in carbon credits. Halder Venture said the planned investment would support its entry into agri-technology and carbon-credit commercialisation, while helping improve efficiency across the agricultural value chain. The proposed acquisition would give Halder Venture a controlling interest if completed.
The disclosed ₹6.25 crore funding is smaller than the stated ₹30.16 crore consideration for InQube. However, the source does not state that the P.K. Bio-Link funding will finance this acquisition. It also does not confirm completion of the InQube transaction, so investors should distinguish the announced term-sheet investment from a completed acquisition.
Got a follow-up? Ask IRIS
What operational changes has Halder Venture made in FY26?
Halder Venture operationalised its Haldia packing and tank farm facility during FY26 and expanded its branded distribution network. The company’s core business covers rice and edible oils, including sourcing, processing, packaging and distribution, with operations rooted in Eastern India.
The company sells rice under the Bhojmoti and Diva brands and edible oils under the Odaana and Omaana brands in India and overseas markets. Its overseas presence includes subsidiaries in West Africa and Singapore, placing group operations closer to export customers. Halder Venture completed the acquisition of Hal Exim Pte. Ltd. in March 2024.
The group structure was also simplified in January 2025, when five operating entities were amalgamated into the listed company. JDM Commercial Private Limited, P. K. Agri Link Private Limited, P. K. Cereals Private Limited, Reliable Advertising Private Limited and Shri Jatadhari Rice Mill Private Limited were folded into Halder Venture.
This consolidation created a single listed agri-platform and reduced the number of separate operating entities. The Haldia facility, distribution expansion and group restructuring indicate that the company has been building its processing, packing, storage and market-access infrastructure alongside its technology investment plans.
What do the reported financial and market figures show?
Halder Venture processed rice and edible oils with FY26 revenue of about ₹646 crore, according to the available company-related data. The same data notes that FY26 profit relied on a ₹30.97 crore foreign-exchange gain, an item investors may separate from operating performance when reviewing earnings quality.
A news update also reported September-quarter consolidated net profit of ₹2.06 crore. The supplied material does not provide the corresponding revenue, prior-year profit, margin or exact reporting year for that quarterly figure. It therefore does not support a detailed quarter-on-quarter or year-on-year earnings comparison.
In the provided peer-comparison table, Halder Venture was shown at a price-to-earnings ratio of 8.23. This was lower than RECODE at 29.61, JKIPL at 101.57, PURPLEUTED at 21.27, SUSAN at 9.99 and AAREYDRUGS at 72.16, while MANAKSIA was at 6.01. The figures are a valuation reference only and do not establish relative growth, debt levels or profitability.
No share-price movement, market-capitalisation change or investor reaction was included in the supplied disclosures. The direct market relevance of the funding is therefore the confirmed capital receipt and the need for investors to monitor subsequent disclosures on its terms, deployment and any change in outstanding equity.
Conclusion
Halder Venture’s July 24 funding closure confirms a ₹6.25 crore capital receipt from P.K. Bio-Link after shareholder approval. It follows a period in which the company consolidated five operating entities, brought its Haldia packing and tank farm facility into operation, broadened distribution and outlined a move into agri-technology through InQube.
The key next item to watch is progress on the proposed ₹30.16 crore purchase of 52% of InQube, which has a disclosed completion timeline of 24 months from definitive agreements. Investors can also track future disclosures for the funding terms and use of proceeds, the Haldia platform’s operational contribution, and earnings that separate recurring performance from foreign-exchange gains.


